Discovery US 2023
The starting point for any desired biological effect is a drug-target interaction, an interaction that can be studied in a live cellular setting using the CETSA® technology. Drug hunters are now expanding the therapeutic target space to include harder to drug targets like non-enzymatic proteins, shallow protein-protein interactions, and flexible proteins like transcription factors.
This focus further stresses the importance of target validation and understanding the molecular mode of action of the drugs. Because the CETSA® technology platform is label- and tag-free new targets and modalities can be studied in a physiological and therapeutically relevant way, which I will illustrate through a series of use-cases.
We are delighted to share that we will be taking part in the upcoming Drug Discovert US 2023. We are headed to Cambridge, MA with:
- Exhibitin booth (#7)
- 30 min presentation
- Our team of experts
We eagerly anticipate the opportunity to meet you at the conference.
Empower Your Project with Label and Tag Freedom
Submit your inquiry, and let’s work together to find a solution for you.
We anticipate seeing you at the Drug Discovery US 2023 conference.